Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stake Decreased by American Century Companies Inc

Finally, KCG Holdings Inc. raised its stake in shares of Alnylam Pharmaceuticals by 8.1% in the first quarter. FMR LLC now owns 13,723,153 shares of the biopharmaceutical company's stock worth $1,094,559,000 after purchasing an additional 815,270 shares during the period. The Manufacturers Life Insurance Company lifted its stake in Alnylam Pharmaceuticals by 7.0% during the second quarter. Vanguard Group Inc. now owns 6,419,508 shares of the biopharmaceutical company's stock valued at $512,020,000 after acquiring an additional 759,295 shares during the last quarter. Baillie Gifford & Co. lifted its holdings in shares of Alnylam Pharmaceuticals by 2.9% during the second quarter. BlackRock Inc. boosted its holdings in Alnylam Pharmaceuticals by 9.3% in the second quarter. KCG Holdings Inc. now owns 31,800 shares of the biopharmaceutical company's stock worth $1,630,000 after buying an additional 2,374 shares during the last quarter. Segall Bryant & Hamill LLC purchased a new stake in shares of Alnylam Pharmaceuticals during the 3rd quarter valued at $235,000. Credit Suisse AG now owns 248,364 shares of the biopharmaceutical company's stock worth $12,729,000 after buying an additional 69,697 shares during the last quarter.

In other Alnylam Pharmaceuticals news, SVP Laurie Keating sold 30,000 shares of the company's stock in a transaction dated Friday, December 1st. Following the completion of the sale, the senior vice president now directly owns 41,500 shares of the company's stock, valued at approximately $5,639,435. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The shares were acquired at an average price of $71.87 per share, for a total transaction of $21,381,396.87. Also, major shareholder Sanofi purchased 297,501 shares of the company's stock in a transaction dated Wednesday, May 31st. Over the last ninety days, insiders have sold 393,212 shares of company stock worth $48,109,436. The stock of La-Z-Boy Incorporated (NYSE:LZB) earned "Outperform" rating by Barrington Research on Thursday, August 20.

Several equities research analysts have weighed in on the company. Piper Jaffray Companies reaffirmed a "buy" rating and set a $182.00 target price on shares of Alnylam Pharmaceuticals in a research report on Friday, November 17th. Piper Jaffray Companies reissued an "overweight" rating and issued a $14.71 price target (down from $188.00) on shares of Alnylam Pharmaceuticals in a research report on Thursday, November 2nd. Jefferies maintained it with "Buy" rating and $102.0 target in Thursday, August 24 report. Finally, Nomura began coverage on Alnylam Pharmaceuticals in a research report on Thursday, September 14th. (NASDAQ:ALNY) latest ratings and price target changes.

Among 7 analysts covering La-Z-Boy (NYSE:LZB), 2 have Buy rating, 0 Sell and 5 Hold. KeyBanc Capital Markets has "Buy" rating and $36.0 target. Alnylam Pharmaceuticals, Inc. has a one year low of $35.98 and a one year high of $147.63. (ALNY) traded up $1.93 during midday trading on Friday, hitting $125.59. The fund owned 278,347 shares of the biopharmaceutical company's stock after selling 4,720 shares during the quarter. The quick ratio, on the other hand, is 9.8 indicating the company's current short-term liquidity. (NASDAQ:ALNY). California State Teachers Retirement Systems has invested 0.02% of its portfolio in Alnylam Pharmaceuticals, Inc. They expect $-1.36 EPS, down 3.03% or $0.04 from last year's $-1.32 per share. The business had revenue of $17.10 million for the quarter, compared to analysts' expectations of $28.15 million.

Price-to-free-cash-flow (P/FCF) of *tba gives an overview of the equity valuation for Alnylam Pharmaceuticals, Inc. The firm's quarterly revenue was up 24.8% compared to the same quarter previous year. During the same quarter a year ago, the firm posted ($1.21) EPS. The figure allows investors to understand how effectively Alnylam Pharmaceuticals, Inc.is able to convert its money into net income. If you are accessing this story on another site, it was copied illegally and republished in violation of U.S. & global trademark & copyright law.

Alnylam Pharmaceuticals Company Profile Alnylam Pharmaceuticals, Inc is a biopharmaceutical company. The companyÂ's clinical development programs include Patisiran, which is in Phase III clinical trial for the treatment of transthyretin-mediated amyloidosis; Fitusiran, an investigational RNAi therapeutic that is in Phase I/II clinical trial for the treatment of hemophilia and rare bleeding disorders; and Inclisiran (ALN-PCSsc), which is in Phase II clinical trial for hypercholesterolemia.

Notícias recomendadas

  • Vinyl copies of Prince's rare unreleased Black Album LP discovered

    Vinyl copies of Prince's rare unreleased Black Album LP discovered

    Executive Vice President, says that he recently received a correspondence from an individual asking about the value of the record. In 1987, Prince was planning to release The Black Album LP and ordered 500,000 copies to be pressed by record label Warner Bros.
    Newcastle players cancel Christmas party to focus on matches

    Newcastle players cancel Christmas party to focus on matches

    I think it's the right thing. "If you're asking me for a number, no I do not have one but at least we are talking". We have to progress and it's so obvious that we can improve things".

    How Does Microsoft Corporation (MSFT) Stack Up Right Now?

    The company has a market cap of $658,440.25, a PE ratio of 25.25, a price-to-earnings-growth ratio of 1.99 and a beta of 0.99. Ullmann Financial Group Inc. purchased a new position in shares of Microsoft during the first quarter worth about $132,000.
  • Free Press' Stephen Henderson terminated for misconduct

    Free Press' Stephen Henderson terminated for misconduct

    Free Press editor and Vice President Peter Bhatia said: "This is a devastatingly sad day for us at the Free Press ". I dedicated 18 years to this newspaper over three decades, all of it performing at the highest level.
    U.S.  judge blocks Trump anti-contraception measure

    U.S. judge blocks Trump anti-contraception measure

    The 2014 Supreme Court ruling extended the religious exemption afforded to houses of worship to more health insurance providers. California, as well as Washington and MA have also sued the Trump administration in hopes of blocking the rules.
    Erdogan: Muslim nations to seek UN 'annulment' of Trump's Jerusalem move

    Erdogan: Muslim nations to seek UN 'annulment' of Trump's Jerusalem move

    He added that his administration would begin a process of moving the United States embassy from Tel Aviv to Jerusalem. He described his decision to recognize Jerusalem as the seat of Israel's government as merely based on reality.
  • Filmmaker Morgan Spurlock admits to sexual misconduct

    Filmmaker Morgan Spurlock admits to sexual misconduct

    He described the note as "an apology" in a follow-up message on Facebook, saying that he wants to be "part of the solution". Spurlock says prior to this post , his first wife was the only person he had ever told about being the victim of abuse.
    Health department to you: Step away from your smartphone

    Health department to you: Step away from your smartphone

    In case you will watch a motion picture stream it with Wi-Fi and watch it with cell benefit not working", Smith said. The guidelines released were stated as a precaution, but the report notes that the science is not conclusive on this.
    First look at Hawk and Dove in DC's live-action Titans series

    First look at Hawk and Dove in DC's live-action Titans series

    If they're received well, they could even spin off to their own show on Warner Bros.' still-in-development DC streaming service. For more on the DC superhero team, check out IGN's deep dive into the history of the Teen Titans .
  • Leonard Fournette out of practice again on Thursday

    Leonard Fournette out of practice again on Thursday

    BC-FBN-Jaguars Injuries, 111Jaguars list RB Fournette as questionable against TexansEds: APNewsNow. Fournette (quad) did not take part in Friday's practice, Mike Kaye of FirstCoastNews.com reports.
    Lemieux Laughs: Saunders Can KO Me? Maybe With a Baseball Bat!

    Lemieux Laughs: Saunders Can KO Me? Maybe With a Baseball Bat!

    Lemieux is so confident of a victory that he boasted it would take a low blow from a baseball bat for him to lose to Saunders. Ingle remonstrated with the officials and had to be dragged away as promoter Frank Warren then supervised Lemieux's re-weigh.
    Black Women in Congress Say Alabama's Doug Jones Should be Seated Now

    Black Women in Congress Say Alabama's Doug Jones Should be Seated Now

    On Tuesday night, Jones credited minority support for his win in his victory speech. "I am just so proud of my state ". In one instance, he said, a voter presented an acceptable form of identification but the poll worker didn't accept it.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.